588 related articles for article (PubMed ID: 30099826)
21. An inverse interaction between
Zhang Y; Yuan Y; Li Y; Zhang P; Chen P; Sun S
Epigenetics; 2019 Oct; 14(10):949-960. PubMed ID: 31144606
[No Abstract] [Full Text] [Related]
22. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.
Tao L; Huang G; Wang R; Pan Y; He Z; Chu X; Song H; Chen L
Sci Rep; 2016 Dec; 6():38408. PubMed ID: 27922075
[TBL] [Abstract][Full Text] [Related]
23. Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling.
Tan WX; Sun G; Shangguan MY; Gui Z; Bao Y; Li YF; Jia ZH
Sci Rep; 2020 Sep; 10(1):14768. PubMed ID: 32901049
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.
Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L
Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536
[TBL] [Abstract][Full Text] [Related]
26. SNHG6 functions as a competing endogenous RNA to regulate E2F7 expression by sponging miR-26a-5p in lung adenocarcinoma.
Liang R; Xiao G; Wang M; Li X; Li Y; Hui Z; Sun X; Qin S; Zhang B; Du N; Liu D; Ren H
Biomed Pharmacother; 2018 Nov; 107():1434-1446. PubMed ID: 30257360
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA AK089579 inhibits epithelial-to-mesenchymal transition of peritoneal mesothelial cells by competitively binding to microRNA-296-3p via DOK2 in peritoneal fibrosis.
Zhang XW; Wang L; Ding H
FASEB J; 2019 Apr; 33(4):5112-5125. PubMed ID: 30652956
[TBL] [Abstract][Full Text] [Related]
28. Deregulation of lncRNA-AC078883.3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN/AKT.
Xing S; Qu Y; Li C; Huang A; Tong S; Wu C; Fan K
J Cell Physiol; 2019 Dec; 234(12):22657-22665. PubMed ID: 31111480
[TBL] [Abstract][Full Text] [Related]
29. miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1.
Li J; Li S; Chen Z; Wang J; Chen Y; Xu Z; Jin M; Yu W
Tumour Biol; 2016 Oct; 37(10):13287-13294. PubMed ID: 27460077
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis.
Zhu ZJ; Pang Y; Jin G; Zhang HY; Wang WH; Liu JW; Tuo GX; Wu P; Yang Y; Wang ZQ; Wang K
Aging (Albany NY); 2021 Jun; 13(13):17155-17176. PubMed ID: 34081626
[TBL] [Abstract][Full Text] [Related]
31. CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis.
Zheng F; Xu R
Biomed Pharmacother; 2020 Apr; 124():109828. PubMed ID: 31986409
[TBL] [Abstract][Full Text] [Related]
32. LINC01089 suppresses lung adenocarcinoma cell proliferation and migration via miR-301b-3p/STARD13 axis.
Qian Y; Zhang Y; Ji H; Shen Y; Zheng L; Cheng S; Lu X
BMC Pulm Med; 2021 Jul; 21(1):242. PubMed ID: 34281560
[TBL] [Abstract][Full Text] [Related]
33. lncRNA HOXA11-AS is involved in fracture healing through regulating mir-124-3p.
Wang XN; Zhang LH; Cui XD; Wang MX; Zhang GY; Yu PL
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4771-4776. PubMed ID: 29164588
[TBL] [Abstract][Full Text] [Related]
34. LINC00115 regulates lung adenocarcinoma progression via sponging miR-154-3p to modulate Sp3 expression.
Sun K; Lu T; Hu C; Li Z; Zhu J; Zhang L; Shao X; Chen W
Mol Cell Probes; 2023 Apr; 68():101909. PubMed ID: 36889558
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA HOXA11-AS knockout inhibits proliferation and overcomes drug resistance in ovarian cancer.
Chen Y; Cui Z; Wu Q; Wang H; Xia H; Sun Y
Bioengineered; 2022 May; 13(5):13893-13905. PubMed ID: 35706412
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-133a-3p Inhibits Lung Adenocarcinoma Development and Cisplatin Resistance through Targeting GINS4.
Zhou Y; Yan J; Chen H; Zhou W; Yang J
Cells Tissues Organs; 2024; 213(1):55-66. PubMed ID: 36273455
[TBL] [Abstract][Full Text] [Related]
37. MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3.
Qi MM; Ge F; Chen XJ; Tang C; Ma J
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5242-5250. PubMed ID: 31298375
[TBL] [Abstract][Full Text] [Related]
38. MiR-490-3p Sponged by lncRNA NEAT1 Can Attenuate Lung Adenocarcinoma Progression by Suppressing the RhoA/ROCK Signaling Pathway.
Zhao L; Ren C; Fang Y; Li P; Zhang H; Zuo L; Zhang J; Zhao J
Ann Clin Lab Sci; 2023 Jan; 53(1):42-51. PubMed ID: 36889766
[TBL] [Abstract][Full Text] [Related]
39. Linc00426 accelerates lung adenocarcinoma progression by regulating miR-455-5p as a molecular sponge.
Li H; Mu Q; Zhang G; Shen Z; Zhang Y; Bai J; Zhang L; Zhou D; Zheng Q; Shi L; Su W; Yin C; Zhang B
Cell Death Dis; 2020 Dec; 11(12):1051. PubMed ID: 33311443
[TBL] [Abstract][Full Text] [Related]
40. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.
Ren N; Jiang T; Wang C; Xie S; Xing Y; Piao D; Zhang T; Zhu Y
Aging (Albany NY); 2020 Jun; 12(11):11025-11041. PubMed ID: 32516127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
